IBM Clinical Development Blog

More Executives Choose to Migrate Studies Off Questionable Data Platforms

[fa icon="calendar"] Mar 28, 2016 1:50:26 PM / by Amy Young

Topics: EDC, eclinical systems, data migration

Are you concerned about the financial viability of your current EDC vendor? Perhaps you should be. 

At eClinicalOS, we're used to customers switching to us after their current trials are finished. But recently, we've noticed a new trend – companies switching to our platform mid-study. 
One look at the media and it's easy to see why some are making the move: stories of mismanagement and poor financial performance at some vendors are unfortunately all-too common. 
But why are they choosing eClinicalOS?  We like to think it's because of our solid reputation, super-fast study build, and affordable pay-as-you-go model.  Our new customers also tell us it's because of these points:  
  • Financial stability
    Over the years, we've maintained stable executive leadership. And with our recent acquisition by IBM, we're now backed by one of the most powerful and successful companies in the world.  
  • Regulatory and operational best practices
    Our operating procedures and management practices are tested by more than 50 audits each year. Notably, we have never failed an audit!
  • Migration expertise
    We have unmatched experience in safely and efficiently migrating active clinical studies to our platform. 

What would you do if you lost all of your study data due to a failing vendor? Don't wait to find out. Contact us today to find out how you can protect your data by migrating it to our platform. Often, we can provide a quote in 24 hours or less.

Get my quote


Share this post

Amy Young
Written by Amy Young